Gara Jalqabaatti › Obesity › Missouri › Kansas City
Qorannoo klinikaalii Obesity Kansas City, MO keessatti
Qorannoo 11 Obesity f Kansas City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
- Kansas City Veterans Affairs Medical Center, Kansas City
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Kansas City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Kansas City
- Research Site, Kansas City
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Saint Luke's Hospital of Kansas City, Kansas City
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kansas City VA Medical Center, Kansas City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Kansas City
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Research Consultants, JCCT Co, Kansas City
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
Namoota walitti qabaa jiraSadarkaa 1
- MBX Biosciences Investigational Site, Kansas City
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
- University Health, Kansas City
- University of Missouri-Kansas City, Kansas City
Qorannoo Obesity magaalota biroo keessatti
- Houston, TXQorannoo 43
- Chicago, ILQorannoo 41
- New York City, NYQorannoo 40
- San Antonio, TXQorannoo 40
- Washington, DCQorannoo 33
- Orlando, FLQorannoo 32
- Dallas, TXQorannoo 30
- Boston, MAQorannoo 28
- Las Vegas, NVQorannoo 27
- Miami, FLQorannoo 27
- Baltimore, MDQorannoo 26
- Jacksonville, FLQorannoo 25
Qorannoo biroo Kansas City keessatti
- Saree OljooQorannoo 34
- Kansara Qara'a Non-Small CellQorannoo 31
- Cufama OnneeQorannoo 25
- Saree (Gosoota Hunda)Qorannoo 21
- Dhibee QaraQorannoo 19
- Kansarii ColorectalQorannoo 16
- Kansara MetastatikiiQorannoo 15
- Leukemia Myeloidii HamaaQorannoo 15
- Kansarii ProstateQorannoo 14
- Kansarii OvariiQorannoo 11
- Sukkaraa Gosa 2Qorannoo 11
- Dhibee Onneessaa fi DhiigaQorannoo 11
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.